|
2017 / 2018 |
| 6/1/18 | Tariq Rana, Ph.D. | Professor of Pediatrics |
TBD |
| 5/4/18 | Olivier Harismendy, Ph.D. | Asst. Professor of Medicine |
TBD
|
| 4/6/18 | S. Park, MD | Bejar Lab |
Genomic Correlates of IL-2 Response in Advanced Melanoma and Renal Cell Carcinoma
|
| 3/2/18 | Ayush Kishore, Ph.D. | Gutkind Lab |
GNAQ-FAK Signaling in Ocular Melanoma |
| 2/2/18 | Nathan Jameson | Furnari Lab |
Epigenetic regulation of EGFR in Glioblastoma |
| 1/5/18 | Peter Ly, Ph.D. | NIH Pathway to Independence Awardee |
Rebuilding After Catastrophe: How Cell Division Errors Shape the Cancer Genome |
| 12/1/17 | Elaine Guo, BS | Kolodner Lab |
Synthetic Lethal Targeting of BRCA-Deficient Cancer |
| 11/3/17 | Jason Ear, Ph.D. | Ghosh Lab |
Dissecting the Role of DAPLE in Colorectal Cancer |
| 10/6/17 | Carlos Medina, BS | Dowdy Lab |
Genomics of Recurrent Acute Myeloid Leukemia |
| 9/1/17 | Myan Do, BA | Willert Lab |
Wnt Receptor FZD7 in Cancers and ES Cells |
|
2016 / 2017 |
| 6/2/17 | Jill Mesirov, Ph.D. | Medicine |
Computational Cancer Genomics |
| 5/5/17 | Nathan Jameson, Predoc Trainee | Furnari Lab |
Understanding EGFRVIII Genomic Breakpoints through CRISPR Modeling |
| 4/7/17 | Wendy Huang, Ph.D. | Cellular and Molecular Medicine |
RNA Helicases and Non-Coding RNA in Immune Regulation |
| 3/3/17 | Mohit Jain, MD, Ph.D. | Medicine and Pharmacology |
Cancer Metabolomics |
| 2/3/17 | Sven Heinz, Ph.D. | Cellular and Molecular Medicine |
Medical Epigenomics in Chronic Lymphocytic Leukemia |
| 1/6/17 | Matteo D'Antonio, Ph.D. | Frazer Lab |
Kataegis Expression Signature in Breast Cancer is Associated with Late Onset, Better Prognosis and Higher HER2 Levels |
| 12/2/16 | Jin Zhang, Ph.D. | Pharmacology |
Spatiotemporal Regulation of Signaling |
| 11/4/16 | Hannah Carter, Ph.D. | Medicine and Bioengineering |
Network Perturbing Cancer Mutations |
| 10/7/16 | Guowei Wu | Fu Lab |
SRPK1 Inhibition in Cancer Signaling |
| 9/9/16 | Debashis Sahoo, Ph.D. | Pediatrics and Computer Science |
A New Framework to Understand Cancer Cells
|
|
2015 / 2016 |
| 5/6/16 | Christie Eissler, Ph.D. | Zhou Lab |
The Role of Sumoylation in Chromosome Translocation |
| 4/1/16 | Guowei Wu | Fu Lab |
SRPK1: A Tumor Suppressor, Oncogene or Both? |
| 3/4/16 | Elaine Guo | Kolodner Lab |
Synthetic Lethality Relationships Involving Genome Instability |
| 2/5/16 | Nicholas Kalogriopoulos | Ghosh Lab |
Cross-Talk Between RTKs and Trimeric G Proteins |
| 1/8/16 | Nathan Jameson | Furnari Lab |
Chromatin Dynamics and Dysregulation Caused by EGFRvIII Deletion in Glioblastoma |
| 12/4/15 | Xiang-Dong Fu, Ph.D. | Fu Lab |
SRPK1: A Potential Key Cancer Target |
| 11/6/15 | Peter Ly, Ph.D. | Cleveland Lab |
Fragmentation and Reassembly of a Specific Human Chromosome in Micronuclei |
| 10/2/15 | Kelly Frazer, Ph.D. | Pediatrics |
Identification of Driver Mutations in Distal Regulatory Elements in Breast Cancer |
| 9/4/15 | Clark Chen, MD/Ph.D. | Neurosurgery |
Epigenetic Regulation of Glioblastoma Tumor Initiation |
|
2014 / 2015 |
| 7/10/15 | Jun Bao Fan, Ph.D. | Zhang Lab |
ISG15/Protein in Cancer Development: Friend or Foe? |
| 6/5/15 | Sebastian Gomez-Cavazos, Ph.D. | Oegema Lab |
Exploring the roles of Plk1 and the Chromosome Passenger Complex during Cytokinesis |
| 5/1/15 | Aaron Springer | Dowdy Lab |
Treating Cancer with BioReversible Prodrug RNAi Therapeutics |
| 4/3/15 | Cara Bickers | Traver Lab |
Lineage Tracing of Hematopoietic Stem and Progenitors in Zebrafish |
| 3/6/15 | Nicholas Kalogriopoulos | Ghosh Lab |
Role of G Proteins in Tumor Glucophagy: Lessons Learned From Diabetes |
| 2/13/15 | Christie Eissler, Ph.D. | Zhou Lab |
Investigating the Role of Protein SUMOylation in Cell Cycle Dynamics and Genome Stability |
| 1/9/15 | Gen-Sheng Feng, Ph.D. | Feng Lab |
Dissecting the Contradictory Roles of Signaling Molecules in Liver Cancer |
| 12/5/14 | Maricel Gozo, Ph.D. | Cheresh Lab |
Stress-Induced Reprogramming of Epithelial Cancers |
| 11/7/14 | Pradipta Ghosh, MD/Ph.D. | Ghosh Lab |
Molecular Engineering to Explore, Access, and Modulate a Cancer Cell's Signaling Code |
| 10/3/14 | Paul Mischel, Ph.D. | Mischel Lab |
Targeting EGFR-P13-mTOR Signaling: A Central Role of mTORC2 in Cancer Metabolic Reprogramming |
| 9/5/14 | Karen Oegema, Ph.D. | Oegema Lab |
Dynamic Cytoskeletal Rearrangement Underlying Cell Division in Cancer |
|
2013 / 2014 |
| 7/11/14 | Steve Dowdy, Ph.D. | Dowdy Lab |
Death of a Dogma, Cyclin D Activates Rb by Mono-Phosphorylation |
| 6/6/14 | Aaron Springer | Dowdy Lab |
Treating Cancer with BioReversible siRNN Produg RNAi Therapeutics |
| 5/2/14 | Julia Nussbacher | Yeo Lab |
Roles of RNA Binding Proteins in RNA Metabolism and Protein Translation |
| 4/4/14 | Amelia Richardson | Desai Lab |
Functional Analysis of Cohesin Mutants in Human Cancer |
| 3/7/14 | Trey Ideker, Ph.D. | Ideker Lab |
Mapping the Genetic Networks of Cancer |
| 2/7/14 | Kun-Liang Guan, Ph.D. | Guan Lab |
The Hippo-YAP Pathway in Organ Size Control and Tumorigenesis |
| 1/10/13 | Cara Bickers | Traver Lab |
Building Tools for a Zebrafish Leukemia Model |
| 12/6/13 | Frank Furnani, Ph.D. | Furnani Lab |
EGF Receptor in Glioma Biology: Therapeutic Target and a Multifaceted Driver of Pathogenicity |
| 11/1/13 | Peter Ly, Ph.D. | Cleveland Lab |
Chromosomal Fragmentation Chromothripsis in Cancer |
| 10/4/13 | Maricel Gozo, Ph.D. | Cheresh Lab |
Determining Novel Strategies to Overcome EGFR Resistance |
| 9/6/13 | David Traver, Ph.D. | Traver Lab |
Normal and Neoplastic Hematopoiesis |
|
2013 / 2012 |
| 7/5/13 | Richard Kolodner, Ph.D. | Kolodner Lab |
DNA Damage Repair Mechanisms Drive Cancer |
| 6/7/13 | Stephanie Weng | Zhang Lab |
Exploring Mechanisms to Reduce Leukemogenic Potential of AML-1-ETO |
| 5/3/13 | Alex Hamil | Dowdy Lab |
siRNN Induced RNAi Responses to Treat Cancer |
| 4/5/13 | Gene Yeo, Ph.D. | Yeo Lab |
Studies of RNA Binding Proteins Associated with Neurological Disease |
| 2/1/13 | Brian Thacker | Esko Lab |
The Role of Heparan Sulfate 3-O Sulfation in Tumor Angiogenesis |
| 1/4/13 | Nicholas Vinckier | Sander Lab |
The Roles of SOX9, HES1, and NGN3 in Progression of Pancreatic Ductal Adnocarcinoma (PDAC) |
| 12/7/12 | Julia Nussbacher | Yeo Lab |
RNA Binding Protein Regulation of RNA Metabolism |
| 11/2/12 | Pradipta Ghosh, MD/Ph.D. | Ghosh Lab |
Transactivation of G-Protein by Tyrosine Kinases |
| 10/5/12 | Kirsten Ludwig, Ph.D. | Wang Lab |
Stem Cell Growth Factor Control of Colon Cancer Invasiveness |
| 9/7/12 | Amelia Richardson | Desai Lab |
Cohesin Complexes Mutations in Cancer |
|
2011 / 2012 |
| 6/1/12 | Nicholas Vinckier | Sander Lab |
Notch Signaling in Progression of Pancreatic Ductal Adenocarcinoma (PDAC) |
| 5/4/12 | Alex Hamil | Dowdy Lab |
Induction of Synthetic Lethal RNAi Response to Treat Cancer |
| 4/6/12 | Anthony Beas | Farquhar Lab |
Gas Regulation of EEA1 Shuts Down Proliferation Signaling Through GIV (Girdin) |
| 3/2/12 | Stephanie Weng | Zhang Lab |
Haploinsufficiency in t(8;21) AML Patients |
| 2/3/12 | Brian Thacker | Esko Lab |
Heparan Sulfate 3-O Sulfotransferases in Cancer |
| 1/6/12 | Jean Wang, Ph.D. | Wang Lab |
Resistance of Leukemic Stem Cells to Oncogene Targeted Therapies |
| 12/2/11 | Spencer Wei | Yang Lab |
Epithelial-Mesenchymal Transition (EMT) Programming During Breast Cancer Metastasis |
| 11/1/11 | Brian Meade | Dowdy Lab |
Development of Novel RNAi Therapeutics with New Synthetic Chemistry |
| 10/7/11 | Kirsten Ludwig, Ph.D. | Wang Lab |
p190RhoGap and Anillin Modulation of Rho-GTP During Cleavage Furrow Formation |
| 9/9/11 | Steve Dowdy, Ph.D. | Dowdy Lab |
Regulation of G1 Cell Cycle Progression in Cancer |